The core activity of HekeTiss is the development and marketing of innovative therapies for the treatment of chronic wounds, particularly through the use of stem cells derived from adipose tissue. The company focuses on the development of skin substitute products, such as TrophiPatch, a cell-based skin patch that promotes wound healing through the angiogenic and regenerative properties of stem cells.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
✓ Offered
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Regenerative therapies for chronic wounds, based on adipose-derived stem cells, to promote vascularisation and support wound healing.
TrophiPatch™
Allogeneic, cell-based skin patch technology with adipose-derived stem cells in a carrier matrix, for revascularisation of damaged tissue and accelerated wound healing; in clinical Phase I/IIa evaluation.
Research and development in wound healing
Research on adipose-derived stromal cells, angiogenic properties, regenerative effects, and preclinical or clinical development for chronic wounds.